Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
52 week high
|
Strong Performer, Getting Expensive
1182.0000
-24.00
(
-1.99
%)
NSE
May 12, 2026
15:07 PM
New 52W High today
Volume:
557.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
17 Nov 2022
52 week high
1182.00
-1.99%
Natco Pharma
Hold:
Natco Pharma Ltd.
by
ICICI Direct
Target: 660
Target
ICICI Direct
Number of FII/FPI investors increased from 254 to 285 in Mar 2026 qtr.
More from Natco Pharma Ltd.
Recommended
Market trades lower, Syrma SGS Technology's Q4FY26 net profit soars 55% YoY
Trendlyne Marketwatch |
12 May 2026, 03:06PM
IPO listing pace holds strong: Three more debuts this week after last week's trio
|
11 May 2026, 06:13PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020